Canada: Food, Drugs, Healthcare, Life Sciences

On Sept. 8, 2025, Health Canada and the Public Health Agency of Canada published their Report on Red Tape Reduction, outlining their key regulatory modernization initiatives aimed at improving efficiency, transparency and responsiveness within Canada's health system.

Cooling towers contaminated with Legionella bacteria at a Sofina Foods Ltd. meat processing plant in London, Ontario have been linked to multiple outbreaks of Legionnaires' disease during the summers of 2024 and 2025.

Across Canada, the federal and provincial governments continue to increase regulation of per- and polyfluoroalkyl substances ("PFAS") in tandem with scientific findings...

Doctors and nurses in Canada can be sued for medical malpractice (also called medical negligence) if they provide care that falls below the accepted medical standard and that failure causes...

On Sept. 8, 2025, Health Canada and the Public Health Agency of Canada published their Report on Red Tape Reduction, outlining their key regulatory modernization initiatives aimed at improving efficiency, transparency and responsiveness within Canada's health system.

On August 25, 2025, Health Canada released its first annual report (the Report) summarizing anonymized self assessment data received in respect of the reporting period beginning September 29, 2023, and ending September 28, 2024, from signatories to the Canadian Product Safety Pledge for Consumer Products and Cosmetics.

Doctors and nurses in Canada can be sued for medical malpractice (also called medical negligence) if they provide care that falls below the accepted medical standard and that failure causes...

On Sept. 8, 2025, Health Canada and the Public Health Agency of Canada published their Report on Red Tape Reduction, outlining their key regulatory modernization initiatives aimed at improving efficiency, transparency and responsiveness within Canada's health system.

Cooling towers contaminated with Legionella bacteria at a Sofina Foods Ltd. meat processing plant in London, Ontario have been linked to multiple outbreaks of Legionnaires' disease during the summers of 2024 and 2025.

On June 8, 2012, Genentech’s lawsuit seeking a declaration that US Patent No. 6,733,752 was invalid and not-infringed by Genentech’s trastuzumab product (HERCEPTIN).

Health Canada specifically contemplates certain proteins as SEBs in its Guidance, although Health Canada has not limited SEBs to only particular classes of drugs.

On May 23, 2012, the Federal Court held that Merck Frosst Canada Ltd. ("Merck") is liable to Apotex Inc. ("Apotex") for damages under section 8 of the Patented Medicines (Notice of Compliance) Regulations (the "Regulations"), but exercised its discretion to reduce the amount of compensation payable based on a defence of ex turpi causa.